Travere Therapeutics (TVTX) Depreciation & Amortization (CF) (2013 - 2026)
Travere Therapeutics (TVTX) reported Depreciation & Amortization (CF) of $4.23 million for Q2 2026, down 69.8% from $14.02 million a year earlier and down 83.2% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Travere Therapeutics' Depreciation & Amortization (CF) came in at $63.37 million, up 26.4% year-over-year; for FY2025, it came in at $60.74 million, up 39.5% from FY2024.
- Depreciation & Amortization (CF) has increased for four consecutive years, with a five-year compound annual growth rate of 19.8% (FY2020 to FY2025).
- By year, Depreciation & Amortization (CF) came in at $43.56 million in FY2024 (+13.0%), $38.53 million in FY2023 (+86.0%), $20.72 million in FY2022 (+62.6%) and $12.75 million in FY2021 (-48.1%).
- The Q2 2026 figure ranks as the lowest quarterly Depreciation & Amortization (CF) since Q3 2022.
- Year over year, Depreciation & Amortization (CF) gained in six of the last eight quarters, with growth averaging 26.0%.
- The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2026 (growth of 96.9%); the low point was Q2 2026 (a decline of 69.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $25.21 million (Q1 2026), $18.14 million (Q4 2025) and $15.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Travere Therapeutics | 5.35 Bn | 4.95 Bn | 167.41 Mn | 4.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.23 Mn |
| Mar 31, 2026 | 25.21 Mn |
| Dec 31, 2025 | 18.14 Mn |
| Sep 30, 2025 | 15.79 Mn |
| Jun 30, 2025 | 14.02 Mn |
| Mar 31, 2025 | 12.80 Mn |
| Dec 31, 2024 | 12.09 Mn |
| Sep 30, 2024 | 11.24 Mn |
| Jun 30, 2024 | 10.35 Mn |
| Mar 31, 2024 | 9.88 Mn |
| Dec 31, 2023 | 9.49 Mn |
| Sep 30, 2023 | 11.48 Mn |
| Jun 30, 2023 | 10.95 Mn |
| Mar 31, 2023 | 6.62 Mn |
| Dec 31, 2022 | 6.31 Mn |
| Sep 30, 2022 | -793,000.00 |
| Jun 30, 2022 | 8.11 Mn |
| Mar 31, 2022 | 7.09 Mn |
| Dec 31, 2021 | -7.82 Mn |
| Sep 30, 2021 | 7.87 Mn |
API Access
Travere Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();